DOUGLAS WALTER CRAWFORD

Allopathic & Osteopathic Physicians|Family Medicine RICHLAND, WA NPI 1912944786

General Payments — all program years on this page

$14,561.38

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 724
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $792.58 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $663.5012
Education $129.084

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $344.508
Acerta Pharma LLC $298.456
ABBVIE INC. $124.991
Bayer HealthCare Pharmaceuticals Inc. $24.641

By program year

Program yearAmountRecords
2018 $3,560.82173
2019 $2,969.42160
2020 $2,607.24144
2021 $2,722.83157
2022 $1,476.0863
2023 $432.4111
2024 $792.5816

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086142843 Bayer Healthcare Pharmaceuticals Inc. $24.64 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096575829 Novo Nordisk Inc $124.82 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096889834 Novo Nordisk Inc $79.78 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097047776 Novo Nordisk Inc $32.27 02/07/2024 Education Undisputed 01/23/2026 View at CMS
1097119747 Novo Nordisk Inc $4.79 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097279898 Novo Nordisk Inc $32.27 02/07/2024 Education Undisputed 01/23/2026 View at CMS
1097512066 Novo Nordisk Inc $32.27 02/07/2024 Education Undisputed 01/23/2026 View at CMS
1097570734 Novo Nordisk Inc $6.03 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097724234 Novo Nordisk Inc $32.27 02/07/2024 Education Undisputed 01/23/2026 View at CMS
1103513808 ABBVIE INC. $124.99 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104279065 AstraZeneca Pharmaceuticals LP $14.07 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104687088 AstraZeneca Pharmaceuticals LP $15.03 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105568097 AstraZeneca Pharmaceuticals LP $14.57 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105666080 AstraZeneca Pharmaceuticals LP $101.61 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105676121 AstraZeneca Pharmaceuticals LP $124.14 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105767626 AstraZeneca Pharmaceuticals LP $29.03 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.